|
|
Michael Johnston: The first half of 2012 is now in the books, dropping the curtain on a back-and-forth six months for many investors. Though the sentiment recently Read more…
Eric Dutram: In the last five years, investors have witnessed a variety of market conditions. Stocks were relatively strong in the middle part of 2007 but, as we all know, proceeded to fall apart during the turmoil of 2008 and one of the worst recessions in recent memory. Read more…
Despite the recent economic turmoil in Europe, the Biotech Industry has been home to some of the strongest performers in the market in 2012. The SPDR S&P Biotech ETF (NYSEARCA:XBI) and the First Trust NYSE Arca Biotech Index ETF (NYSEARCA:FBT) year-to-date are up Read more…
In trading on Thursday, the iPath Short Extended Russell 1000 TR ETN (NYSEArca:ROSA) is outperforming other ETFs, up about 12.30% on the day. Also up on the day is the Read more…
In trading on Thursday, the C-Tracks Citi Volatility Index TR ETN (NYSE:CVOL) is outperforming other ETFs, up about 35.28% on the day. Also up on the day are the Read more…
NASDAQ:IBB, NYSE:CVOL, NYSE:FBT, NYSE:VIXY, NYSE:VXX, NYSE:XBI
Ron Rowland: Like many of you, I’m a Baby Boomer. Now I find myself north of 50 and the prospect of getting “old” isn’t very attractive. What does this have to do with investing and ETFs? Plenty! Read more…
David Fry: Our goal in this profile is to help investors wade through the many competing ETF offerings available. Using our long experience as an ETF publication, and nearly 40 years in the investment business, we can help select those ETFs that matter and may or may not be repetitive. Read more…
NASDAQ:IBB, NYSE:FBT, NYSE:FXH, NYSE:IHF, NYSE:IYH, NYSE:PPH, NYSE:XBI, NYSE:XLV
US equities ended the session higher on increased trade. All five major indices closed modestly higher with small and mid cap stocks leading the way. The S&P MidCap 400 added 0.8% while the small-cap Russell 2000 (NYSE:IWM) improved by 0.7%. The blue chip DJIA (NYSE:DIA) Read more…
Last week ended relatively flat for the broader indices as markets digested the finalization of the 2011 Tax Plan, but there were some pockets of performance in various sectors and asset classes. Read more…
In today’s volatile markets, it’s more important than ever to seek out sectors that have potential to grow regardless of continuing difficult economic conditions. One such sector is biotechnology, Read more…
March was the 10th anniversary of the beginning of the “tech wreck” when the NASDAQ peaked at 5132 on March 10, 2000. As we look back ten years and all that has transpired in technology and Read more…
In midday trading Tuesday, the Gold Miners ETF (GDX) is outperforming other ETFs, up about 2.6% on the day. Components of that ETF showing particular strength include shares of Read more…
In midday trading Wednesday, the First Trust Biotech ETF (FBT) is outperforming other ETFs, up about 3.3% on the day. And underperforming Read more…
Most Comments